Welcome to our dedicated page for Lifeway Foods SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods Inc. filings document the regulatory record for an Illinois operating company whose common stock trades on the Nasdaq Global Market under the symbol LWAY. Its Form 8-K reports cover operating results, sales estimates, Regulation FD disclosures, material agreements, director appointments and resignations, and compensatory arrangements under the company's 2022 Omnibus Incentive Plan.
Proxy materials describe annual shareholder meeting matters, board and committee governance, executive compensation and equity-plan administration. The filing record also identifies the company's registered securities, including common stock and preferred stock purchase rights, and includes formal disclosures related to financial reporting, governance changes and capital-structure matters.
The issuer LWAY submitted a Form 144 notice related to proposed sales of Common Stock. The filing lists a holding of 111,548 shares and includes multiple reported dispositions in the prior three months: 24,000, 25,000, 50,000, and 38,452 shares, with transaction dates in May–June 2026. The sales show corresponding gross proceeds listed in dollars. The filing also notes a prior gift date of 05/19/2023.
Lifeway Foods, Inc. reported that shares held through the Ludmila Smolyansky Trust 2/1/05 were sold in two open-market transactions. The trust, for which Ludmila Smolyansky is trustee, sold 40,000 shares of common stock on June 24, 2026 at a weighted average price of $30.12 per share.
On June 25, 2026, the trust sold an additional 45,616 shares at a weighted average price of $29.65 per share, bringing total reported sales to 85,616 shares. Following these sales, the trust continues to indirectly hold 607,207 shares of Lifeway Foods common stock.
Lifeway Foods, Inc. major shareholder Edward Smolyansky sold a total of 38,452 shares of common stock in open-market transactions on June 24, 2026. The reported weighted average prices were about $29.82 and $30.52, with individual trades executed between $29.26 and $31.24.
After these sales, he continues to hold more than 1,000,000 shares directly, and additional shares are held indirectly. Indirect holdings include shares in a trust where he is trustee, shares held by his son that he disclaims beneficial ownership of, and shares held by Smolyansky Holding LLC, which he also disclaims except for any pecuniary interest.
LWAY Rule 144 notice reporting recent sales of Common Stock. The filing lists three dispositions by Edward Smolyansky: 24,000 shares on 05/15/2026 for $588,466.02, 25,000 shares on 05/14/2026 for $632,323.18, and 50,000 shares on 06/22/2026 for $1,309,920.00. The cover line also references 38,452 shares and an aggregate value of $1,148,880.64.
LifeWay Foods, Inc. related securities were reported for resale under a Form 144 by broker-dealer RBC Capital Markets LLC in connection with holdings attributed to Michael Smolyansky and Ludmila Smolyansky. The filing lists proposed sale activity dated 06/24/2026 and multiple completed sales in the prior three months.
The filing shows three transactions: 15,000 shares sold on 04/20/2026 for $397,500.00, 20,000 shares sold on 05/15/2026 for $492,722.00, and 20,000 shares sold on 06/10/2026 for $478,914.00. The securities are Common Stock of LifeWay Foods, Inc., listed on NASDAQ.
LWAY filing reports a proposed sale of 50,000 shares of Common Stock under Rule 144. The notice also discloses recent dispositions by Edward Smolyansky of 24,000 shares on 05/15/2026 for $588,466.02 and 25,000 shares on 05/14/2026 for $632,323.18.
The filing lists a prior gift transaction dated 05/19/2023 involving 50,000 shares to Ludmila Smolyansky. The filing provides sale counts and dollar amounts for recent transactions; proceeds recipients and exact timing of the proposed Rule 144 sale beyond the registered quantity are not specified in the excerpt.
Lifeway Foods, Inc. insider Edward Smolyansky reported an open-market sale of 50,000 shares of common stock at a weighted average price of $26.20 per share. The shares were sold by the Edward Smolyansky Trust 2/2/16, for which he serves as trustee, in multiple trades between $26.00 and $26.99. Following this transaction, the Form 4 shows 1,183,333 shares held indirectly by the trust, 1,052,642 shares held directly, and 100,000 shares held by his son, which he disclaims. Additional shares are held by Smolyansky Holding LLC, where he disclaims beneficial ownership except for any pecuniary interest.
Lifeway Foods, Inc. reported results of its 2026 Annual Meeting of Shareholders. Of 15,281,888 common shares entitled to vote, 13,982,124 were represented, establishing a quorum. Shareholders elected seven board nominees, including CEO Julie Smolyansky, to serve until the 2027 annual meeting.
Investors also ratified Grant Thornton LLP as independent registered public accountants, and approved executive compensation on a nonbinding advisory basis. A separate director, Jason Scher, was elected for a term through the 2027 meeting. The company furnished a CEO investor presentation highlighting Lifeway’s leading kefir brand, revenue growth to about $212.5 in FY 2025 with a 15.8% CAGR, no outstanding debt at 12/31/2025, and planned capital investment of approximately $48 in its Waukesha, Wisconsin manufacturing facility.
Lifeway Foods, Inc. CEO, President and Secretary Julie Smolyansky reported a series of equity compensation events, mainly exercises of performance share units and restricted stock units into common stock on June 16–17, 2026.
She exercised a total of 130,830 share-based awards into common stock and 57,466 shares of common stock were surrendered to the issuer to satisfy tax withholding obligations, with footnotes stating that no stock was sold. Following these transactions, her directly held common stock reported in this filing totaled 2,212,095 shares.
Lifeway Foods, Inc. CFO Eric A. Hanson reported equity compensation activity involving restricted stock units and common shares. On June 16, 2026, 2,390 restricted stock units were exercised into the same number of shares of common stock, recorded as a grant or award at $0.00 per share. Of these shares, 994 common shares valued at $24.79 per share were surrendered to the company to cover tax withholding obligations; the footnotes state that no stock was sold in the market. After these transactions, Hanson directly owned 59,884 shares of common stock. Footnotes also indicate that additional restricted stock units remain outstanding, with tranches of 743 and 742 units scheduled to vest on March 28, 2027 and March 28, 2028, 1,261 units scheduled to vest on January 10, 2027, and 891, 891, and 890 units scheduled to vest on March 6 of 2027, 2028, and 2029, contingent on his continued service.